Figures & data
Figure 1 Patient disposition.
Table 1 Baseline patient demographics
Figure 2 Patient fluxes between major treatment modalities over the one-year study period in Group 1 (upper panel) and Group 2 (lower panel). Treatments could be changed (adding, deleting pharmaceutical interventions) for safety reasons at any time, for lack of efficacy every three months, and for any reason including inconvenience, at six months.
Note: *Numbers represent choices after completion of the visit.
Figure 3 Change in use frequency (%) of antidiabetic drugs.
Table 2 Primary and secondary efficacy endpoints
Table 3 Adverse events and hypoglycemia in the EXPERIENCE trial